Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$EVGN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 up 72.00% YoY • Reported revenue of $0.35M down -60.75% YoY • Evogene expects full-year 2026 cash usage to be approximately $8.5 million to $9.5 million, compared with approximately $14.4 million in 2025 and approximately $20.5 million in 2024, with further reductions targeted.

Price since post

Full Details

Advertisement|Remove ads.